Fast delivery within 72 Hours
CeraVe SA Lotion for Rough & Bumpy Skin 237ml | USA | Smooth & Exfoliate
Rs. 9,020.00 Original price was: Rs. 9,020.00.Rs. 8,580.00Current price is: Rs. 8,580.00.
8 in stock
- Exfoliates and smooths rough, bumpy skin
- Contains salicylic acid for gentle exfoliation
- Hydrates with ceramides and hyaluronic acid
- Non-comedogenic and fragrance-free
- 237ml bottle for targeted skin smoothing
8 in stock
Shipping & Delivery
-
Courier delivery
Our courier will deliver to the specified address
2-3 Days
From $20
-
DHL Courier delivery
DHL courier will deliver to the specified address
2-3 Days
From $40
-
Warranty 1 year
-
Free 30-Day returns
Black Friday Blowout!
Specification
Overview
Processor
Display
RAM
Storage
Video Card
Connectivity
Features
Battery
General
Description
CeraVe SA Lotion for Rough & Bumpy Skin 237ml – Smooth and Exfoliate
The CeraVe SA Lotion for Rough & Bumpy Skin 237ml is designed to gently exfoliate and smooth rough and bumpy skin. Formulated with salicylic acid, this lotion helps to soften and improve skin texture by removing dead skin cells without causing irritation. The addition of essential ceramides and hyaluronic acid ensures the skin remains hydrated and protected, while improving its natural barrier.
Benefits of CeraVe SA Lotion
- Exfoliates rough and bumpy skin with salicylic acid
- Softens skin without causing irritation
- Contains ceramides to restore the skin’s protective barrier
- Non-comedogenic, fragrance-free, and hypoallergenic
- Suitable for dry, rough, and bumpy skin types
How to Use
Apply the CeraVe SA Lotion daily to dry, rough, and bumpy areas of the skin. Massage it gently until fully absorbed. Use consistently for smoother skin texture. Do not use on broken or inflamed skin.
Product Details
- Brand: CeraVe
- Size: 237ml
- Skin Type: Rough and Bumpy
- Main Ingredients: Salicylic Acid, Ceramides, Hyaluronic Acid
Customer Reviews
Only logged in customers who have purchased this product may leave a review.

Reviews
Clear filtersThere are no reviews yet.